NCT06375096

Brief Summary

to evaluate bone mineral density in children with graves' disease

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2024

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 25, 2024

Completed
25 days until next milestone

First Posted

Study publicly available on registry

April 19, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

June 25, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 25, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 25, 2025

Completed
Last Updated

April 19, 2024

Status Verified

April 1, 2024

Enrollment Period

1 year

First QC Date

March 25, 2024

Last Update Submit

April 17, 2024

Conditions

Bone Density, LowBone Mineral Density in Children With Graves' Disease

Outcome Measures

Primary Outcomes (1)

  • bone mineral density

    measure bone mineral density in children diagnosed with graves' disease, to evaluate the effect of the disease on it and the effect of antithyroid medication after that

    1 month

Interventions

evaluate bone mineral densityOTHER

observation effect of graves' in bone mineral density in children

Eligibility Criteria

Age2 Years - 18 Years
Sexall
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

children diagnosed with graves' disease, more than 2 years and less than 18 years

You may qualify if:

  • age at enrollment ≥2 years to \< 18 years
  • both sexes
  • the patients should be diagnosed with graves'

You may not qualify if:

  • patients less than 2 years
  • patients more than 18 years
  • Controlled GD patients on antithyroid
  • patients with other endocrine diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Bone Diseases, Metabolic

Condition Hierarchy (Ancestors)

Bone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Central Study Contacts

Hadeer Youssef Mahmoud

CONTACT

01110548137hadeeryoussef754@gmail.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Bone mineral density in children diagnosed with graves' disease

Study Record Dates

First Submitted

March 25, 2024

First Posted

April 19, 2024

Study Start

June 25, 2024

Primary Completion

June 25, 2025

Study Completion

June 25, 2025

Last Updated

April 19, 2024

Record last verified: 2024-04